Jason Ehrlich
2021
In 2021, Jason Ehrlich earned a total compensation of $27.9M as Chief Medical Officer and Chief Development Officer at Kodiak Sciences, a 814% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $254,948 |
|---|---|
| Option Awards | $25,844,150 |
| Salary | $479,000 |
| Stock Awards | $1,323,150 |
| Other | $45,303 |
| Total | $27,946,551 |
Ehrlich received $25.8M in option awards, accounting for 92% of the total pay in 2021.
Ehrlich also received $254.9K in non-equity incentive plan, $479K in salary, $1.3M in stock awards and $45.3K in other compensation.
Rankings
In 2021, Jason Ehrlich's compensation ranked 174th out of 12,405 executives tracked by ExecPay. In other words, Ehrlich earned more than 98.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 174 out of 12,405 | 99th |
Division Manufacturing | 45 out of 5,494 | 99th |
Major group Chemicals And Allied Products | 15 out of 2,369 | 99th |
Industry group Drugs | 11 out of 2,090 | 100th |
Industry Biological Products, Except Diagnostic Substances | 8 out of 452 | 98th |
Source: SEC filing on April 25, 2023.
Ehrlich's colleagues
We found two more compensation records of executives who worked with Jason Ehrlich at Kodiak Sciences in 2021.
News
Kodiak Sciences CEO Victor Perlroth's 2023 pay slips 9% to $2.7M
April 23, 2024
Kodiak Sciences CEO Victor Perlroth's 2022 pay falls 97% to $3M
April 25, 2023
Kodiak Sciences CEO Victor Perlroth's 2020 pay falls 49% to $8.9M
April 28, 2021
Kodiak Sciences CEO Victor Perlroth's 2019 pay jumps 199% to $18M
April 28, 2020
Kodiak Sciences CEO Victor Perlroth's 2018 pay jumps 616% to $5.9M
April 24, 2019